Sabby Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Sabby Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,214	Closed	-$6.49M	–	382
2016 Q1	$6.49M	Buy	1,214 +26	+2%	+$1.92K	0.32%	36
2015 Q4	$13.4M	Buy	1,188 +1,088	+1,088%	+$120K	0.74%	20
2015 Q3	$1.18M	Sell	100 -239	-71%	-$31.2K	0.05%	216
2015 Q2	$2.63M	Buy	+339	New	+$22.2K	0.1%	140

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Sabby Management's ANAC Position: Q2 2016 in Review

Sabby Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 44,439 shares — an estimated $2.38M sold.

Sabby Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $2.38M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Sabby Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Sabby Management sold 44,439 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.38M.
Sabby Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Sabby Management's ANACOR PHARMACEUTICALS INC COM position peaked at $2.38M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Sabby Management's 13F filing for Q2 2016, filed 15 Aug 2016.